2m 2m 2m 2m 2m 2m 2m
Eli Lilly & Co (LLY)
NYSE
$1,255.25-$0.15 (-0.01%)
Price as of Aug 21, 2026 7:59 PM EDT- $1.1TMarket Cap
- 77.51%1-Year Change
- Drug Manufacturers - GeneralIndustry
Eli Lilly & Co (LLY)
$1,255.25-$0.15 (-0.01%)
LLY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1,255.40 | ||
Change | +$11.00 (+0.88%) | ||
Open | $1,232.00 | ||
High | $1,271.22 | ||
Low | $1,230.00 | ||
Previous Close | $1,244.40 | ||
Volume | 2,506,149 | ||
30-Day Average Volume | 2,719,698 | ||
1-Week Change | 6.38% | ||
1-Month Change | 6.96% | ||
1-Year Change | 77.51% | ||
3-Year Change | 132.98% | ||
5-Year Change | 384.92% | ||
Fundamentals | |||
Shares Outstanding | 891.4M | ||
Total Assets | $142.3B | ||
Market Cap | $1.1T | ||
Enterprise Value | $1.2T | ||
Period: QTR TTM FY | |||
Revenue | $23.0B | ||
Net Income | $7.1B | ||
Free Cash Flow | $10.7B | ||
EBIT | $9.2B | ||
EBITDA | $9.8B | ||
Net Working Capital | $16.9B | ||
EPS | $7.94 | ||
Enterprise Value/EBITDA | 119 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 33 | ||
P/E | 158 | ||
PEG | -41 | ||
Price/Free Cash Flow | 105 | ||
Price/Operating Cash Flow | 105 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 0.55% | ||
Trailing Annual Dividend Yield | 0.53% | ||
Ex-Dividend Date | 08/14/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield